Streck Inc

A medical industry leader since 1971, Streck was a pioneering force in the development of cell stabilization technologies. The manufacturer’s efforts moved laboratories’ counting of blood cells from time-consuming manual methods to automatic, calibrated techniques that proved a breakthrough for hematology labs. Streck continues to work and build innovative products for the laboratory including collection tubes and molecular assays. Maintaining a La Vista, Nebraska, production facility spanning 200,000 square feet, Streck also produces a comprehensive range of testing and reagent materials that meet the needs of global instrument manufacturers.

Streck’s patented and proprietary products are delivered across 65 countries to approximately 13,000 clinical labs. Among its cellular and genetic technologies are antibiotic resistance detection and monitoring kits and flow cytometry controls. The company is committed to intensive research and development, focused on emerging worldwide health issues. The Streck quality commitment is one that bolsters medical organization reputations and has improved the lives of millions of patients worldwide.